204 related articles for article (PubMed ID: 37563649)
21. Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation.
Wu X; Zhou F; Cheng B; Tong G; Chen M; He L; Li Z; Yu S; Wang S; Lin L
PeerJ; 2023; 11():e16317. PubMed ID: 38025711
[TBL] [Abstract][Full Text] [Related]
22. Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer.
Liu Y; Li D; Chen Y; Liu Y; Lin Y; Huang X; Wu T; Wang C; Ding J
BMC Bioinformatics; 2023 May; 24(1):191. PubMed ID: 37161430
[TBL] [Abstract][Full Text] [Related]
23. Expression Patterns of Glycosylation Regulators Define Tumor Microenvironment and Immunotherapy in Gastric Cancer.
Li F; Huang K; Pan C; Xiao Y; Zheng Q; Zhong K
Front Cell Dev Biol; 2022; 10():811075. PubMed ID: 35242759
[TBL] [Abstract][Full Text] [Related]
24. RNA m
Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
Front Immunol; 2022; 13():905057. PubMed ID: 36389669
[TBL] [Abstract][Full Text] [Related]
25. Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer.
Qing X; Xu W; Liu S; Chen Z; Ye C; Zhang Y
Front Immunol; 2022; 13():843077. PubMed ID: 35273618
[TBL] [Abstract][Full Text] [Related]
26. Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer.
Li Z; Zhang X; Weng W; Zhang G; Ren Q; Tian Y
Aging (Albany NY); 2023 Jun; 15(12):5445-5481. PubMed ID: 37319315
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer.
Lin Y; Jing X; Chen Z; Pan X; Xu D; Yu X; Zhong F; Zhao L; Yang C; Wang B; Wang S; Ye Y; Shen Z
Theranostics; 2023; 13(13):4574-4600. PubMed ID: 37649598
[No Abstract] [Full Text] [Related]
28. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
29. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
30. Lymphovascular or perineural invasion is associated with lymph node metastasis and survival outcomes in patients with gastric cancer.
Zhang F; Chen H; Luo D; Xiong Z; Li X; Yin S; Jin L; Chen S; Peng J; Lian L
Cancer Med; 2023 Apr; 12(8):9401-9408. PubMed ID: 36952439
[TBL] [Abstract][Full Text] [Related]
31. Identification of Immunogenic Cell-Death-Related Subtypes and Development of a Prognostic Signature in Gastric Cancer.
Gan X; Tang X; Li Z
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979463
[TBL] [Abstract][Full Text] [Related]
32. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of CLEC11A and its derived immune signature in gastric cancer.
Zheng Q; Gong Z; Li B; Cheng R; Luo W; Huang C; Wang H
Front Immunol; 2024; 15():1324959. PubMed ID: 38348052
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
Song S; Zhang M; Xie P; Wang S; Wang Y
Front Immunol; 2022; 13():978909. PubMed ID: 36341328
[TBL] [Abstract][Full Text] [Related]
35. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J
Front Immunol; 2023; 14():1217590. PubMed ID: 37492563
[TBL] [Abstract][Full Text] [Related]
36. Autophagy-related prognostic signature characterizes tumor microenvironment and predicts response to ferroptosis in gastric cancer.
Li H; Xu B; Du J; Wu Y; Shao F; Gao Y; Zhang P; Zhou J; Tong X; Wang Y; Li Y
Front Oncol; 2022; 12():959337. PubMed ID: 36052243
[TBL] [Abstract][Full Text] [Related]
37. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
38. Pyroptosis Patterns Characterized by Distinct Tumor Microenvironment Infiltration Landscapes in Gastric Cancer.
Xiang R; Ge Y; Song W; Ren J; Kong C; Fu T
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680930
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
[TBL] [Abstract][Full Text] [Related]
40. A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer.
Dong B; Wu Y; Zhang J; Gu Y; Xie R; He X; Pang X; Wang X; Cui Y
Front Immunol; 2023; 14():1162876. PubMed ID: 37215130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
